ACHV logo

Achieve Life Sciences (ACHV) Total Liabilities

Annual Total Liabilities

$20.82 M
-$849.00 K-3.92%

31 December 2023

ACHV Total Liabilities Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly Total Liabilities

$16.54 M
-$5.97 M-26.51%

30 September 2024

ACHV Quarterly Total Liabilities Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

ACHV Total Liabilities Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-3.9%-18.5%
3 y3 years+591.2%+433.7%
5 y5 years+534.3%+393.6%

ACHV Total Liabilities High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3 years-3.9%+591.2%-27.1%+433.7%
5 y5 years-3.9%+591.2%-27.1%+895.1%
alltimeall time-54.8%+1636.9%-64.1%+1473.3%

Achieve Life Sciences Total Liabilities History

DateAnnualQuarterly
Sept 2024
-
$16.54 M(-26.5%)
June 2024
-
$22.51 M(+9.4%)
Mar 2024
-
$20.57 M(-1.2%)
Dec 2023
$20.82 M(-3.9%)
$20.82 M(+2.6%)
Sept 2023
-
$20.30 M(+5.6%)
June 2023
-
$19.22 M(-5.6%)
Mar 2023
-
$20.36 M(-6.1%)
Dec 2022
$21.67 M(+11.3%)
$21.67 M(-4.5%)
Sept 2022
-
$22.68 M(+8.9%)
June 2022
-
$20.82 M(+8.5%)
Mar 2022
-
$19.18 M(-1.5%)
Dec 2021
$19.47 M(+546.5%)
$19.47 M(+528.4%)
Sept 2021
-
$3.10 M(-34.2%)
June 2021
-
$4.71 M(+31.8%)
Mar 2021
-
$3.57 M(+18.7%)
Dec 2020
$3.01 M(-0.5%)
$3.01 M(+55.1%)
Sept 2020
-
$1.94 M(+1.1%)
June 2020
-
$1.92 M(+15.5%)
Mar 2020
-
$1.66 M(-45.1%)
Dec 2019
$3.03 M(-7.7%)
$3.03 M(-9.6%)
Sept 2019
-
$3.35 M(+3.1%)
June 2019
-
$3.25 M(-24.6%)
Mar 2019
-
$4.31 M(+31.4%)
Dec 2018
$3.28 M(+63.0%)
$3.28 M(+10.2%)
Sept 2018
-
$2.98 M(+7.2%)
June 2018
-
$2.78 M(+19.8%)
Mar 2018
-
$2.32 M(+15.2%)
Dec 2017
$2.01 M(-37.0%)
$2.01 M(-14.2%)
Sept 2017
-
$2.35 M(+32.2%)
June 2017
-
$1.77 M(-11.8%)
Mar 2017
-
$2.01 M(-37.1%)
Dec 2016
$3.20 M(-84.6%)
$3.20 M(-70.0%)
Sept 2016
-
$10.65 M(-23.6%)
June 2016
-
$13.95 M(-4.6%)
Mar 2016
-
$14.63 M(-29.6%)
Dec 2015
$20.77 M(-6.6%)
$20.77 M(-29.5%)
Sept 2015
-
$29.46 M(-16.2%)
June 2015
-
$35.16 M(+114.9%)
Mar 2015
-
$16.36 M(-26.4%)
Dec 2014
$22.23 M(+20.3%)
$22.23 M(-6.6%)
Sept 2014
-
$23.80 M(+2.3%)
June 2014
-
$23.27 M(+15.1%)
Mar 2014
-
$20.22 M(+9.4%)
Dec 2013
$18.48 M(+16.9%)
$18.48 M(+2.1%)
Sept 2013
-
$18.10 M(+8.9%)
June 2013
-
$16.62 M(+10.2%)
Mar 2013
-
$15.09 M(-4.6%)
Dec 2012
$15.81 M(-57.4%)
$15.81 M(-42.3%)
Sept 2012
-
$27.41 M(-17.7%)
June 2012
-
$33.30 M(-10.2%)
Mar 2012
-
$37.09 M(-0.1%)
Dec 2011
$37.13 M(-18.9%)
$37.13 M(+7.1%)
Sept 2011
-
$34.66 M(-21.8%)
June 2011
-
$44.33 M(+2.8%)
Mar 2011
-
$43.10 M(-5.9%)
Dec 2010
$45.79 M(-0.5%)
$45.79 M(+36.8%)
Sept 2010
-
$33.47 M(+10.7%)
June 2010
-
$30.24 M(-16.4%)
Mar 2010
-
$36.17 M(-21.4%)
DateAnnualQuarterly
Dec 2009
$46.02 M(+1027.1%)
$46.02 M(+1186.9%)
Sept 2009
-
$3.58 M(+3.8%)
June 2009
-
$3.44 M(+27.5%)
Mar 2009
-
$2.70 M(-33.8%)
Dec 2008
$4.08 M(-69.4%)
$4.08 M(-14.4%)
Sept 2008
-
$4.77 M(-46.5%)
June 2008
-
$8.92 M(-21.0%)
Mar 2008
-
$11.29 M(-15.4%)
Dec 2007
$13.35 M(-47.6%)
$13.35 M(-28.8%)
Sept 2007
-
$18.74 M(+8.2%)
June 2007
-
$17.32 M(-11.7%)
Mar 2007
-
$19.63 M(-22.9%)
Dec 2006
$25.45 M(+12.4%)
$25.45 M(+11.0%)
Sept 2006
-
$22.93 M(-0.7%)
June 2006
-
$23.08 M(+2.6%)
Mar 2006
-
$22.49 M(-0.7%)
Dec 2005
$22.65 M(+548.4%)
$22.65 M(+298.1%)
Sept 2005
-
$5.69 M(+129.6%)
June 2005
-
$2.48 M(-0.7%)
Mar 2005
-
$2.50 M(-28.5%)
Dec 2004
$3.49 M(+61.8%)
$3.49 M(+44.8%)
Sept 2004
-
$2.41 M(-6.1%)
June 2004
-
$2.57 M(+28.6%)
Mar 2004
-
$2.00 M(-7.4%)
Dec 2003
$2.16 M(-2.3%)
$2.16 M(-21.3%)
Sept 2003
-
$2.74 M(+6.6%)
June 2003
-
$2.57 M(+20.2%)
Mar 2003
-
$2.14 M(-3.1%)
Dec 2002
$2.21 M(+84.4%)
$2.21 M(-21.8%)
Sept 2002
-
$2.83 M(+16.1%)
June 2002
-
$2.43 M(+67.5%)
Mar 2002
-
$1.45 M(+21.1%)
Dec 2001
$1.20 M(-79.3%)
$1.20 M(+14.0%)
Sept 2001
-
$1.05 M(-53.2%)
June 2001
-
$2.25 M(-62.1%)
Mar 2001
-
$5.93 M(+2.2%)
Dec 2000
$5.80 M(-27.9%)
$5.80 M(-26.4%)
Sept 2000
-
$7.88 M(+0.9%)
June 2000
-
$7.81 M(-0.4%)
Mar 2000
-
$7.84 M(-2.5%)
Dec 1999
$8.04 M(-28.8%)
$8.04 M(-12.6%)
Sept 1999
-
$9.20 M(-1.1%)
June 1999
-
$9.30 M(-16.2%)
Mar 1999
-
$11.10 M(-1.8%)
Dec 1998
$11.30 M(+8.7%)
$11.30 M(-5.8%)
Sept 1998
-
$12.00 M(+6.2%)
June 1998
-
$11.30 M(+5.6%)
Mar 1998
-
$10.70 M(+2.9%)
Dec 1997
$10.40 M(+4.0%)
$10.40 M(+5.1%)
Sept 1997
-
$9.90 M(+3.1%)
June 1997
-
$9.60 M(+7.9%)
Mar 1997
-
$8.90 M(-11.0%)
Dec 1996
$10.00 M(+14.9%)
$10.00 M(+7.5%)
Sept 1996
-
$9.30 M(+1.1%)
June 1996
-
$9.20 M(-2.1%)
Mar 1996
-
$9.40 M(+8.0%)
Dec 1995
$8.70 M(-28.7%)
$8.70 M(-37.9%)
Sept 1995
-
$14.00 M(+14.8%)
Dec 1994
$12.20 M
$12.20 M

FAQ

  • What is Achieve Life Sciences annual total liabilities?
  • What is the all time high annual total liabilities for Achieve Life Sciences?
  • What is Achieve Life Sciences annual total liabilities year-on-year change?
  • What is Achieve Life Sciences quarterly total liabilities?
  • What is the all time high quarterly total liabilities for Achieve Life Sciences?
  • What is Achieve Life Sciences quarterly total liabilities year-on-year change?

What is Achieve Life Sciences annual total liabilities?

The current annual total liabilities of ACHV is $20.82 M

What is the all time high annual total liabilities for Achieve Life Sciences?

Achieve Life Sciences all-time high annual total liabilities is $46.02 M

What is Achieve Life Sciences annual total liabilities year-on-year change?

Over the past year, ACHV annual total liabilities has changed by -$849.00 K (-3.92%)

What is Achieve Life Sciences quarterly total liabilities?

The current quarterly total liabilities of ACHV is $16.54 M

What is the all time high quarterly total liabilities for Achieve Life Sciences?

Achieve Life Sciences all-time high quarterly total liabilities is $46.02 M

What is Achieve Life Sciences quarterly total liabilities year-on-year change?

Over the past year, ACHV quarterly total liabilities has changed by -$3.76 M (-18.52%)